» Articles » PMID: 38995417

People with Osteoarthritis Have a Higher Component of Neuropathic Pain As Compared to Those with Rheumatoid Arthritis: A Cross-sectional Study

Overview
Journal Rheumatol Int
Specialty Rheumatology
Date 2024 Jul 12
PMID 38995417
Authors
Affiliations
Soon will be listed here.
Abstract

Neuropathic pain may be present in a proportion of patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Its presence may lead to the requirement of altered management approaches in these conditions. This study investigated the prevalence of neuropathic pain in OA as compared to that in RA. Patients with OA and RA were included cross-sectionally if they had no other known neuropathic disorder. The PainDETECT questionnaire was used to assess neuropathic pain. WOMAC and CDAI scores were used to assess disease severity in OA and RA respectively. 69 patients with OA with a mean WOMAC score of 53.30 ± 16.39 and 98 patients with RA with a mean CDAI of 25.48 ± 16.99 were compared. The median PainDETECT score for OA was 13 (0-30) and RA was 5 (0-37) [p<0.001]. 15 patients with OA and six patients with RA were highly likely to have neuropathic pain, while 15 patients with OA and 30 patients with RA were classified as possibly having neuropathic pain. Thus, the proportion of patients free from neuropathic pain was higher in the RA group (63.3%) than in the OA group (39.1%) [p = 0.003]. Both the prevalence and the severity of neuropathic pain were significantly higher in OA than in RA. These findings suggest that neuropathic pain is an important factor in OA, as in RA, and must be considered in management as well as in future research in both these conditions.

References
1.
Martel-Pelletier J, Barr A, Cicuttini F, Conaghan P, Cooper C, Goldring M . Osteoarthritis. Nat Rev Dis Primers. 2016; 2:16072. DOI: 10.1038/nrdp.2016.72. View

2.
Ding Y, Liu X, Chen C, Yin C, Sun X . Global, regional, and national trends in osteoarthritis disability-adjusted life years (DALYs) from 1990 to 2019: a comprehensive analysis of the global burden of disease study. Public Health. 2023; 226:261-272. DOI: 10.1016/j.puhe.2023.10.030. View

3.
Fu K, Robbins S, McDougall J . Osteoarthritis: the genesis of pain. Rheumatology (Oxford). 2017; 57(suppl_4):iv43-iv50. DOI: 10.1093/rheumatology/kex419. View

4.
Georgiev T, Angelov A . Modifiable risk factors in knee osteoarthritis: treatment implications. Rheumatol Int. 2019; 39(7):1145-1157. DOI: 10.1007/s00296-019-04290-z. View

5.
Woolf C . What is this thing called pain?. J Clin Invest. 2010; 120(11):3742-4. PMC: 2965006. DOI: 10.1172/JCI45178. View